These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 640320)

  • 1. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.
    Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
    Am J Epidemiol; 1973 Aug; 98(2):77-87. PubMed ID: 4724998
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I and Type II Herpes virus and abnormal cervical cytology.
    Heyerdahl TD
    Ir Med J; 1974 Aug; 67(16):445-7. PubMed ID: 4417392
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
    Thomas DB; Rawls WE
    Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoperoxidase demonstration of papillomavirus antigen in dysplasia of the uterine cervix].
    Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M; Higashiiwai H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):411-5. PubMed ID: 2984298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to herpesvirus hominis types 1 and 2 among women with neoplastic change of uterine cervix.
    Peltonen R
    Acta Obstet Gynecol Scand; 1975; 54(4):369-72. PubMed ID: 173131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria.
    Adelusi B; Osunkoya BO; Fabiyi A
    Am J Obstet Gynecol; 1975 Dec; 123(7):758-61. PubMed ID: 1106197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls.
    Kawana T; Sakamoto S; Kasamatsu T; Aurelian L
    Gan; 1978 Aug; 69(4):589-91. PubMed ID: 710808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine cervical dysplasia & herpes simplex virus.
    Luthra UK; Kotwani BG; Kochhar M; Khurana B; Seth P; Mohapatra LN; Mitra AB; Bhatnagar P; Prabhakar AK; Agarwal SS
    Indian J Med Res; 1983 Jul; 78 Suppl():60-6. PubMed ID: 6654432
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immune responses to cytomegalovirus in patients with dysplasia of the uterine cervix.
    Neill WA; Norval M
    Gynecol Obstet Invest; 1985; 20(2):96-102. PubMed ID: 2997004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Human papilloma virus (HPV) antigens and DNA in dysplasia and carcinoma of the uterine cervix].
    Yamagata S; Tsuchida S; Yamamoto K; Kawamura N; Nakamura T; Ueki S; Sugawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1334-40. PubMed ID: 2555425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
    Najem SN; Barton IG; Al-Omar LS; Potter CW
    Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
    Pacsa AS; Kummerländer L; Pejtsik B; Pali K
    J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to herpesviruses in patients with cervical cancer and controls.
    Muñoz N; de-Thé G; Aristizabal N; Yee C; Rabson A; Pearson G
    IARC Sci Publ (1971); 1975; (11 Pt 2):45-51. PubMed ID: 191382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to herpesvirus type 2 in breast cancer and cervical cancer patients.
    Adam E; Sanders EK; Melnick JL; Levy AH; Rawls WE
    Cancer; 1974 Jan; 33(1):147-52. PubMed ID: 4810088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.